JY
MGCD

Jeff Yass’s MGC Diagnostics Corporation MGCD Stock Holding History

Jeff Yass’s Portfolio MGCD Stock Details MGCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-16,212
Closed -$106K – 9463
2016
Q2 		$106K Buy
+16,212
New +$96.9K ﹤0.01% 7997

Other funds holding MGCD

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Jeff Yass's MGCD Position: Q3 2016 in Review

Jeff Yass sold out of MGC Diagnostics Corporation (MGCD) in Q3 2016, closing a stake of 16,212 shares — an estimated $106K sold.

Jeff Yass first reported a position in MGCD in Q2 2016 and held it in 1 quarter. The position peaked at $106K in Q2 2016. 14 funds tracked by Wall St. Rank hold MGCD as of Q3 2016.

  • Jeff Yass reported no remaining MGC Diagnostics Corporation position as of Q3 2016 after selling out during the quarter.
  • Jeff Yass sold 16,212 MGC Diagnostics Corporation shares in Q3 2016, an estimated $106K.
  • Jeff Yass first reported a position in MGC Diagnostics Corporation in Q2 2016 and held it in 1 quarter.
  • Jeff Yass's MGC Diagnostics Corporation position peaked at $106K in Q2 2016.
  • 14 funds tracked by Wall St. Rank held MGC Diagnostics Corporation as of Q3 2016.

Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.